Strength in quality: Myosteatosis as a predictor of survival in advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Strength in quality: Myosteatosis as a predictor of survival in advanced hepatocellular carcinoma

Published:2024-08-02 Issue: Volume: Page:
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:UEG Journal

Author:

Campani Claudia¹²^ORCID,Berzigotti Annalisa³^ORCID

Affiliation:

1. Internal Medicine and Liver Unit University Hospital Careggi University of Florence Florence Italy

2. Department of Experimental and Clinical Medicine University of Florence Florence Italy

3. Department of Visceral Surgery and Medicine Inselspital Berne University Hospital University of Berne Bern Switzerland

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ueg2.12645

Reference13 articles.

1. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

2. Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis

3. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma

4. Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP